Obaob, Jaime B.

HRN: 21-40-76  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/25/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
05/25/2022
06/01/2022
IV
1.5g
Q6h
NHW
Waiting Final Action 
05/25/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/25/2022
06/01/2022
600MG
IV
Q8H
-
Waiting Final Action 
05/26/2022
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
05/26/2022
06/01/2022
TOPICAL
N A
Q 12H
Nonhealing Wound R LE
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: